Thursday, January 21st, 2021
DoD/HHS contract will enable onshore production of three vital medicines to treat critically ill patients, including those with COVID-19. CONTINUUS will build the first GMP-certified end-to-end manufacturing facility using its proprietary technology for the production of small-molecule medicines
Click here…
Tuesday, September 22nd, 2020
CONTINUUS signs contract with Roche to develop an “on-demand” continuous manufacturing process for a new antiviral medicine.
CONTINUUS Pharmaceuticals entered into a development contract with Roche to create an end-to-end Integrated Continuous Manufacturing (ICM) process for a new Roche antiviral…
Thursday, April 16th, 2020
“Continuous Pharmaceutical Manufacturing, why the Industry should Accelerate the Adoption of this Technology” CHEManager (16. April 2020) Click on here to learn more.
…
Wednesday, March 18th, 2020
On February 28th our CEO’s, Salvatore Mascia, presented at the National Academy of Sciences to address innovation in pharmaceutical manufacturing and supply chain security to make drugs in the USA.
Click here to learn more.…
Tuesday, January 7th, 2020
“Compact pharmaceutical factory manufactures drugs on demand” Chemistry World (7 January 2020) following our recent peer-reviewed scientific publication this month on ChemComm Click here to learn more.…
Thursday, December 26th, 2019
“Mini-factory churns out drug cheaply and at a furious pace” Nature (26 December 2019): following our recent peer-reviewed scientific publication this month on ChemComm Click here to learn more…
Friday, November 1st, 2019
On October 30th Dr. Janet Woodcock, Director of CDER at the FDA testified before the House Committee on Energy and Commerce, Subcommittee on Health to share her concern on drug manufacturing gradually moving outside the United States.
The FDA believes…
Thursday, September 5th, 2019
We are happy to announce that we completed a $5 M Series B financing.
This round was led by Mark Bamforth, President & CEO at Arranta Bio, with participation by IMA and other investors from previous rounds. Bamforth will also…
Thursday, August 22nd, 2019
CONTINUUS Pharmaceuticals is seeking to hire a Flow Chemist and an Analytical Chemist.
Both offered positions are full-time, you can find more detailed job description at the links below:
Flow Chemist
Analytical Chemist
…
Wednesday, May 15th, 2019
CONTIUNUUS was featured in the latest CDER Impact stories: The article describes the evolution of continuous manufacturing and its impact on U.S. Drug Manufacturing (click here to learn more).…
Wednesday, February 27th, 2019
On the 28th of February, FDA Commissioner Scott Gottlieb, and Janet Woodcock, director of the Center for Drug Evaluation and Research, released a statement on the FDA’s modern approach to advanced pharmaceutical manufacturing (you can find the full statement here).…
Thursday, February 14th, 2019
CONTINUUS have been selected over 200+ applicants to compete the Startup World Cup in Sunnyvale, CA.
The 15 selected teams will compete at the Plug and Play Center on February 21st, 2019.…
Wednesday, January 30th, 2019
Our CEO Salvatore Mascia was part of the panel discussion: “Tailoring your Technology and Business Strategy for Success” at the 2019 CCP Summit in Boston.…
Wednesday, September 26th, 2018
Think Inside the Box! CONTINUUS was featured on a front cover page of pharmacy practice news regarding how ICM can effectively eliminate drug shortages.…
Thursday, September 21st, 2017
CONTINUUS Pharmaceuticals was awarded a Phase IIB SBIR grant from the National Science Foundation to accelerate technical development and commercialization of its ICM technology platform. The grant consists of $500,000 over a two year extension period, which increases the total…
Tuesday, June 13th, 2017
The CONTINUUS Team has met with key FDA representatives for a progress update on the implementation of our end-to-end Integrated Continuous Manufacturing (ICM) process. The picture below includes (from the left) Sap Chattopadhyay, Stephen Born, Salvatore Mascia, Bayan Takizawa, Vida…
Friday, March 24th, 2017
CONTINUUS was featured on PharmTech, including an interview with our Chief Business Officer Bayan Takizawa.…
Wednesday, February 1st, 2017
On January 9th, 2017 CONTINUUS CEO, Salvatore Mascia, was awarded a price for the 2017 Best Italian Start-Up abroad founded by an Italian entrepreneur. The picture shows Salvatore receiving the award by the Italian Minister of Foreign Affairs, Angelino Alfano.…
Thursday, January 26th, 2017
2016 marked a very successful year for CONTINUUS Pharmaceuticals. The team was able to advance its innovative technology platform through work done with the National Science Foundation, as well as projects with commercial partners. As a result, CONTINUUS was able…
Wednesday, December 28th, 2016
CONTINUUS was featured on R&D Magazine in an exclusive Q&A with CONTINUUS Pharmaceuticals on continuous manufacturing operational best practices and trends for 2017.…
Wednesday, November 16th, 2016
CONTINUUS Pharmaceuticals, Inc. was recently awarded a $4.4 M contract by the US Food and Drug Administration (US FDA). The purpose of this collaborative work, entitled “Advancement of Integrated Continuous Manufacturing (ICM) Unit Operations,” is to develop a science and…
Tuesday, November 1st, 2016
Chemical & Engineering News included CONTINUUS Pharmaceuticals in its list of “10 Startups to Watch”. Click here to learn more…
Thursday, March 31st, 2016
Salvatore Mascia met Italian Prime Minister, Matteo Renzi at a breakfast meeting in Boston, together with 14 other young Italian entrepreneurs. During his speech to the Prime Minister, Dr. Mascia introduced CONTINUUS’s ICM technology and mentioned the ongoing collaboration with…
Wednesday, March 23rd, 2016
Salvatore Mascia was invited by the FDA to give a presentation on CONTINUUS’s Integrated Continuous Manufacturing Platform. Dr. Mascia discussed all of the novel continuous manufacturing technologies under development at CONTINUUS, including an end-to-end process control system (based on Delta…
Tuesday, March 1st, 2016
CONTINUUS Pharmaceuticals was awarded a Phase II SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase II grant consists of $750,000 over a two year period, with the opportunity for additional matching funds…
Tuesday, November 3rd, 2015
CONTINUUS Pharmaceuticals expanded its pipeline by securing a contract with a major pharmaceutical client. CONTINUUS will implement its innovative ICM technology platform for a top-selling generic pharmaceutical. “This represents a great opportunity for generic pharmaceutical companies. Implementing ICM will allow…
Tuesday, July 21st, 2015
Salvatore Mascia, CEO, CONTINUUS Pharmaceuticals will present his talk on continuous manufacturing at the PDA Manufacturing Science Workshop in Washington, D.C., on September 30th 2015. Mascia spoke with the PDA Letter about his upcoming talk, and the interview was published…
Tuesday, June 16th, 2015
CONTINUUS Pharmaceuticals presented its technology platform and product offerings at the 2015 BIO International Convention in Philadelphia on June 16. CONTINUUS was one of only twelve companies selected by the National Science Foundation to be featured in the Company Presentations…
Monday, May 4th, 2015
CONTINUUS was featured in the Boston Business Journal, click here to learn more.…
Thursday, April 23rd, 2015
CONTINUUS Pharmaceuticals was selected to present its technology at the 2015 BIO International Convention in Philadelphia during June 15-18. CONTINUUS will showcase its work at the NSF/NIH Bio Innovation Zone, which has been funded by a Phase I SBIR grant…
Wednesday, April 15th, 2015
In the most recent edition of World Pharmaceutical Frontiers, CONTINUUS founder and CEO Salvatore Mascia was featured in an article discussing the future of the pharmaceutical manufacturing industry. In this article, Salvatore puts forth the case for integrated continuous manufacturing…
Friday, April 10th, 2015
CONTINUUS Pharmaceuticals hosted a ribbon-cutting ceremony to celebrate its new facility in Woburn, MA on April 10, 2015. A number of industry and government representatives were in attendance, including CONTINUUS’s strategic partners: I.M.A. Industria Macchine Automatiche, an Italian-based company, global…
Monday, January 12th, 2015
CONTINUUS Pharmaceuticals was awarded a Phase I SBIR grant from the National Science Foundation to further develop its breakthrough ICM technology. This Phase I grant consists of $150,000 over a six month period.…
Tuesday, December 16th, 2014
ICM was featured on the December 2014 Issue of Pharmaceutical Manufacturing. Click here to read the full article outlining the future of the pharmaceutical manufacturing industry. In addition, CONTINUUS Pharmaceuticals was also featured on Pharmaceutical Technology Magazine among the latest…
Thursday, November 6th, 2014
Mansfield, MA (November 6, 2014): New England Controls announced a new partnership agreement with CONTINUUS Pharmaceuticals, a revolutionary spin-out company from the Massachusetts Institute of Technology (MIT). This agreement will create a path for CONTINUUS to bring their Integrated Continuous…
Monday, October 27th, 2014
CONTINUUS Pharmaceuticals is proud to announce that Timothy F. Jamison, Professor of Chemistry at MIT, will join its Board of Advisors. Prof. Jamison is a world renowned expert in continuous flow chemistry and is involved as a principal investigator at…
Tuesday, October 7th, 2014
CONTINUUS Pharmaceuticals delivered a talk during the Innovation Spotlight Session at the Global Pharma Manufacturing Summit 2014 in Boston. CONTINUUS also participated in a Continuous Manufacturing Session at IFPAC 2014 in Cortona, with many other industry leaders in continuous manufacturing,…
Monday, June 9th, 2014
On June 9, 2014, CONTINUUS Pharmaceuticals closed its Series A financing round of $2 M, increasing the total capital raised to over $2.4 M. The round was led by CONTINUUS’s new strategic partner I.M.A. Industria Macchine Automatiche. I.M.A. is a…
Wednesday, February 12th, 2014
…
Thursday, October 17th, 2013
“Integrated Continuous Manufacturing promises to save time and money” Nature 502, 274 (17 October 2013): following our recent peer-reviewed scientific publication this month on Angew. Chem. Int. Click here to learn more…
Friday, October 4th, 2013
CONTINUUS Pharmaceuticals’ CEO, Salvatore Mascia, participated on a panel discussion with other industry leaders at the Biomedical Manufacturing and Technology Networking Summit in San Francisco on Oct 4 2013.…
Tuesday, October 1st, 2013
CONTINUUS Pharmaceuticals is proud to announce two new members of its advisory board. Jonathan Fleming is the Managing Partner of Oxford Bioscience Partners, and Tom Van Laar is the Former Head of Global Technical Operation at Novartis Pharmaceuticals. More information…
Friday, May 24th, 2013
CONTINUUS Pharmaceuticals is among the 128 Finalists at MassChallenge 2013…
Tuesday, May 14th, 2013
The TechConnect Innovation Awards identify the top 20% of submitted technologies as ranked by the TechConnect Corporate & Investment Partner Committee.…
Wednesday, May 1st, 2013
CONTINUUS Pharmaceuticals completed its first seed financing…
Monday, April 15th, 2013
CONTINUUS was among the 2013 MIT $100K LAUNCH contest semifinalists…
Sunday, March 24th, 2013
Novartis-MIT Center for Continuous Manufacturing places second in Wall Street Journal Competition on October 16, 2012.…
Thursday, March 7th, 2013
CONTINUUS is among the “30 breakthrough technologies in the country developed at key universities” that presented at University Research and Entrepreneurship Symposium (URES 2013) in Cambridge on April 3rd…
Thursday, March 7th, 2013
CONTINUUS is among the “Top 50 Innovators” presenting at the Life Sciences and Healthcare Venture Summit in NYC on March 20th…
